Concord Medical Services Holdings Limited (“CCM”or “the Company”) has been deeply engaged in the field of cancer imaging diagnosis and radiotherapy services for a long time, and is committed to providing patients with high quality, international, patient-centered multidisciplinary diagnosis and treatment services. At present, the company owns advanced equipment covering all aspects of early-stage screening, diagnosis, and therapy, including positron emission tomography-computed tomography scanners (PET-CT), computed tomographic scanners (CT), magnetic resonance imaging scanners (MRI), linear accelerators, Gamma Knife and CyberKnife radiosurgery technology, etc., and can carry out both simple and complicated imaging and therapeutic procedures.
Medical imaging devices are the most technically complex and value-adding medical equipment in the medical equipment industry, and are one of the symbols of hospital modernization. As a medical achievement combining both nuclear and information technology, accelerators and cobalt radiation are the current mainstream technologies used in radiotherapy. Radiotherapy equipment utilizes information provided by medical imaging to design and plan the positioning and timing of beam irradiation, to make corresponding radiotherapy plans, and to conduct effective therapies targeted at the lesion locations.
Regarding its radiotherapy equipment, Concord maintains good cooperative relationships with world-class radiotherapy equipment manufacturers such as Elekta, Varian, Accuray, and others whose advanced and high-quality equipment is second-to-none nationwide. Moreover, Concord collaborates with the prestigious U.S. comprehensive cancer center,MD Anderson, in order to ensure that patients come first. Specially-designed radiotherapy plans enhance the radiological dose in the target area to the maximum extent, while minimizing the dose on normal tissue, making the degree of overlap between the dose distribution curve and the contour lines of the tissues and organs very high, and thus ensuring high-level therapeutic effect. In addition, Concord cooperates with top-level domestic and foreign experts, brings patients the most advanced radiotherapy quality control processes and concepts, enhances the therapeutic effect of radiotherapy to the maximum extent, and comprehensively enhances the quality of life for cancer patients.